These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
728 related articles for article (PubMed ID: 12198663)
1. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663 [TBL] [Abstract][Full Text] [Related]
2. Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa. Herath NI; Walsh MD; Kew MC; Young J; Leggett BA; Macdonald GA J Gastroenterol Hepatol; 2004 Jun; 19(6):676-82. PubMed ID: 15151624 [TBL] [Abstract][Full Text] [Related]
3. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842 [TBL] [Abstract][Full Text] [Related]
4. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma. Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301 [TBL] [Abstract][Full Text] [Related]
5. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma]. Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787 [TBL] [Abstract][Full Text] [Related]
6. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369 [TBL] [Abstract][Full Text] [Related]
7. Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis. Yuan RH; Jeng YM; Chen HL; Hsieh FJ; Yang CY; Lee PH; Hsu HC Clin Cancer Res; 2005 Apr; 11(7):2568-75. PubMed ID: 15814635 [TBL] [Abstract][Full Text] [Related]
8. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis. Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Liu J; Lian Z; Han S; Waye MM; Wang H; Wu MC; Wu K; Ding J; Arbuthnot P; Kew M; Fan D; Feitelson MA Oncogene; 2006 Feb; 25(7):1008-17. PubMed ID: 16247464 [TBL] [Abstract][Full Text] [Related]
10. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Matsumura T; Makino R; Mitamura K Clin Cancer Res; 2001 Mar; 7(3):594-9. PubMed ID: 11297254 [TBL] [Abstract][Full Text] [Related]
11. HDPR1, a novel inhibitor of the WNT/beta-catenin signaling, is frequently downregulated in hepatocellular carcinoma: involvement of methylation-mediated gene silencing. Yau TO; Chan CY; Chan KL; Lee MF; Wong CM; Fan ST; Ng IO Oncogene; 2005 Feb; 24(9):1607-14. PubMed ID: 15580286 [TBL] [Abstract][Full Text] [Related]
12. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas. Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867 [TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Inagawa S; Itabashi M; Adachi S; Kawamoto T; Hori M; Shimazaki J; Yoshimi F; Fukao K Clin Cancer Res; 2002 Feb; 8(2):450-6. PubMed ID: 11839663 [TBL] [Abstract][Full Text] [Related]
14. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567 [TBL] [Abstract][Full Text] [Related]
15. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma. Guo C; Liu QG; Yang W; Zhang ZL; Yao YM Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495 [TBL] [Abstract][Full Text] [Related]
16. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors. Chetty R; Serra S; Asa SL Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809 [TBL] [Abstract][Full Text] [Related]
17. [Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers]. Yang JF; Chen SL; Liu ZH; Zhang Y Ai Zheng; 2004 Jul; 23(7):799-802. PubMed ID: 15248915 [TBL] [Abstract][Full Text] [Related]
18. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328 [TBL] [Abstract][Full Text] [Related]
20. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach. Kim HS; Hong EK; Park SY; Kim WH; Lee HS Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]